A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children

Shigella sonnei live vaccine candidate, WRSS1, which was previously evaluated in US, Israeli and Thai volunteers, was administered orally to Bangladeshi adults and children to assess its safety, clinical tolerability and immunogenicity. In a randomized, placebo-controlled, dose-escalation, age-desce...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hum Vaccin Immunother
Autori principali: Raqib, Rubhana, Sarker, Protim, Zaman, K., Alam, Nur Haque, Wierzba, Thomas F., Maier, Nicole, Talukder, Kaisar, Baqui, Abdullah Hel, Suvarnapunya, Akamol E., Qadri, Firdausi, Walker, Richard I., Fix, Alan, Venkatesan, Malabi M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2019
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6663145/
https://ncbi.nlm.nih.gov/pubmed/30794051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1575165
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi